NCT07404046

Brief Summary

Aim: Comparison of tendon to bone ingrowth in bone tunnels and intra-articular remodeling of the graft after anterior cruciate ligament surgery with a muscle-tendon graft and those with a tendon graft. Subjects and methods: It is a single-blind prospective randomized study that would include at least 40 patients with an anterior cruciate ligament rupture. Patients would be randomly divided into two groups of minimally 20 patients each. Patients in the first study group would undergo ACL reconstruction with a muscle-tendon graft, while patients in the control group would be treated with the standard method of ACL reconstruction with a tendon graft. Expected contribution to the field: The assumption is that the obtained results could enable a better understanding of the contribution of remaining muscle fibers on the tendon in anterior cruciate ligament reconstruction operations to the tendon to bone ingrowth and intra-articular remodeling of the graft of operated patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Feb 2026Sep 2027

First Submitted

Initial submission to the registry

December 21, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 11, 2026

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

1.6 years

First QC Date

December 21, 2025

Last Update Submit

February 7, 2026

Conditions

Keywords

ArthroscopyTissue RemodelingAnterior Cruciate LigamentSemitendinosus MuscleKnee

Outcome Measures

Primary Outcomes (1)

  • SNQ

    To analyze and compare T2 signal-to-noise ratio values on magnetic resonance imaging at 6 weeks, 6 and 12 months postoperatively within and between the two study groups. The SNQ is calculated as the ratio of the graft T2 signal intensity to the signal intensity of a reference tissue on MRI. Higher SNQ values indicate higher graft signal, which corresponds to lower graft maturity/quality. Scale: Continuous numerical value (exact values depend on MRI signal calibration).

    6 weeks, 6 and 12 months postoperatively

Secondary Outcomes (9)

  • Bone Tunnel Diameter - Femur

    6 weeks, 6 months, 12 months postoperatively

  • Bone Tunnel Diameter - Tibia

    6 weeks, 6 months, 12 months postoperatively

  • Knee Stability - Anterior Tibial Translation

    12 months postoperatively

  • KOOS - Pain Subscale

    Before surgery, 6 weeks, 6 months, 12 months postoperatively

  • KOOS - Symptoms Subscale

    Before surgery, 6 weeks, 6 months, 12 months postoperatively

  • +4 more secondary outcomes

Study Arms (4)

Tendon

ACTIVE COMPARATOR

Intervention Name: Tendon-only ST graft Procedure/Surgery: Arthroscopic all-inside ACL reconstruction using an autologous semitendinosus tendon graft without meniscus repair. Details: Standard tendon graft preparation and fixation Tunnel creation and concomitant lateral tenodesis Anesthesia per protocol Standardized post-op rehab

Procedure: ACL reconstruction

Tendon + meniscus

ACTIVE COMPARATOR

Intervention Name: Tendon-only ST graft + meniscus repair Procedure/Surgery: Arthroscopic all-inside ACL reconstruction using an autologous semitendinosus tendon graft with concurrent meniscus suture. Details: Standard tendon graft preparation and fixation Tunnel creation and concomitant lateral tenodesis Meniscus repair as needed Anesthesia per protocol Standardized post-op rehab

Procedure: ACL reconstruction

Muscle tendon

ACTIVE COMPARATOR

Intervention Name: Muscle-tendon ST graft Procedure/Surgery: Arthroscopic all-inside ACL reconstruction using an autologous semitendinosus graft preserving muscle fibers, without meniscus repair. Details: Muscle-tendon graft preparation and fixation Tunnel creation and concomitant lateral tenodesis Anesthesia per protocol Standardized post-op rehab

Procedure: ACL reconstruction

Muscle tendon + meniscus

ACTIVE COMPARATOR

Intervention Name: Muscle-tendon ST graft + meniscus repair Procedure/Surgery: Arthroscopic all-inside ACL reconstruction using an autologous semitendinosus graft preserving muscle fibers, with meniscus repair. Details: Muscle-tendon graft preparation and fixation Tunnel creation and concomitant lateral tenodesis Meniscus repair technique as needed Anesthesia per protocol Standardized post-op rehab

Procedure: ACL reconstruction

Interventions

Participants will undergo arthroscopic all-inside anterior cruciate ligament reconstruction using an autologous semitendinosus graft. In the experimental intervention, a muscle-tendon semitendinosus graft is used, with preservation of muscle fibers on the tendon. In the control intervention, a standard tendon-only semitendinosus graft is used. In both groups, graft preparation, tunnel creation, fixation technique, and concomitant lateral tenodesis are identical, and all procedures are performed by the same surgeon following a standardized protocol.

Muscle tendonMuscle tendon + meniscusTendonTendon + meniscus

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Clinically and radiologically confirmed anterior cruciate ligament (ACL) rupture.
  • Age between 18 and 50 years.
  • Intact posterior cruciate ligament and collateral ligaments.
  • Signed informed consent to participate in the study.
  • Patients meeting at least one indication for concomitant lateral tenodesis, including: age under 25 years, positive pivot-shift test, presence of Segond fracture, participation in sports with frequent changes of direction and rotational knee loads, or joint hypermobility (Beighton score ≥ 7).

You may not qualify if:

  • Previous ACL reconstruction of the same knee.
  • Inability to use a graft prepared by quadruple folding of the semitendinosus tendon.
  • Graft diameter \< 7.5 mm.
  • MRI-confirmed unsuccessful meniscal healing after repair.
  • Acute joint infection or history of joint infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital Dubrava

Zagreb, 10000, Croatia

RECRUITING

Central Study Contacts

Marin Glavčić, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

December 21, 2025

First Posted

February 11, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

February 11, 2026

Record last verified: 2026-02

Locations